Cite
MLA Citation
F. Janku et al.. “Preliminary results from an open-label, multicenter phase 1/2 dose escalation and expansion study of THOR-707, a novel not-Alpha IL-2, as a single agent in adult subjects with advanced or metastatic solid tumors.” European journal of cancer, vol. 138, n.d., pp. S11–. http://access.bl.uk/ark:/81055/vdc_100120048175.0x000022